Kidswell Bio Corporation
4584.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥1,556 | ¥1,721 | ¥2,046 | ¥1,286 |
| % Growth | -9.6% | -15.9% | 59% | – |
| Cost of Goods Sold | ¥1,160 | ¥1,123 | ¥1,436 | ¥748 |
| Gross Profit | ¥396 | ¥597 | ¥610 | ¥538 |
| % Margin | 25.4% | 34.7% | 29.8% | 41.8% |
| R&D Expenses | ¥176 | ¥212 | ¥226 | ¥201 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥189 | ¥200 | ¥217 | ¥213 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥365 | ¥413 | ¥444 | ¥414 |
| Operating Income | ¥31 | ¥185 | ¥166 | ¥125 |
| % Margin | 2% | 10.7% | 8.1% | 9.7% |
| Other Income/Exp. Net | -¥119 | -¥9 | ¥41 | -¥18 |
| Pre-Tax Income | -¥88 | ¥176 | ¥207 | ¥107 |
| Tax Expense | ¥8 | ¥18 | ¥40 | ¥53 |
| Net Income | -¥97 | ¥157 | ¥167 | ¥54 |
| % Margin | -6.2% | 9.1% | 8.1% | 4.2% |
| EPS | -1.95 | 3.31 | 3.96 | 1.33 |
| % Growth | -158.9% | -16.4% | 197.7% | – |
| EPS Diluted | -1.95 | 3.28 | 3.96 | 1.33 |
| Weighted Avg Shares Out | 50 | 47 | 42 | 41 |
| Weighted Avg Shares Out Dil | 50 | 42 | 42 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥1 | ¥0 |
| Interest Expense | ¥8 | ¥10 | ¥10 | ¥10 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | -¥125 |
| EBITDA | -¥80 | ¥185 | ¥151 | ¥116 |
| % Margin | -5.1% | 10.8% | 7.4% | 9.1% |